The National Agency for Health Regulation, Control, and Surveillance recently issued Resolution ARCSA-DE-2026-003-DASP. This technical normative framework establishes updated legal and quality requirements to obtain sanitary registration for medical devices in Ecuador.
From a regulatory and pharmaceutical perspective, the framework introduces a modern risk-based classification system. It categorizes devices into four levels, from low to high risk. This ensures tailored conformity assessments for clinical safety and technical efficacy.
A notable regulatory advancement is the implementation of a simplified registration process. Devices previously approved by high-surveillance agencies and IMDRF members will experience optimized market access.
Furthermore, the regulation strengthens post-market surveillance, demanding strict clinical performance monitoring and quality control inspections. These updated and specialized protocols ensure robust compliance with strict international standards, fostering continuous technological innovation in the rapidly expanding Ecuadorian healthcare sector.
